Meeting
2022 ASCO Genitourinary Cancers Symposium
Germline APC (I1307K) mutation and clinical outcomes in prostate cancer.
Authors
Minas P. Economides
The University of Texas MD Anderson Cancer Center, Houston, TX
Minas P. Economides , Mari Nakazawa , Jonathan Lee , Lucas Hollifield , Arjun Vasant Balar , Emmanuel S. Antonarakis , David R Wise
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 40, 2022 (suppl 6; abstr 144)
DOI
10.1200/JCO.2022.40.6_suppl.144
Abstract #
144
Poster Bd #
H5
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Germline APC (I1307K) mutation and clinical outcomes in prostate cancer.
First Author: Minas P. Economides
Poster
2018 ASCO Annual Meeting
Clinical outcomes with cumulative tumor suppressor gene (TSG) alterations in castration sensitive (CSPC) and resistant (CRPC) prostate cancer.
First Author: Anis Hamid
Poster
2024 ASCO Genitourinary Cancers Symposium
Chromatin modifications on plasma ctDNA as a tool to phenotype castration-resistant prostate cancer.
First Author: Asli Munzur
Poster
2023 ASCO Genitourinary Cancers Symposium
Effect of Janus kinase (JAK) signaling inhibition on lineage plasticity and drug sensitivity in castrate resistant prostate cancer.
First Author: Samir Zaidi